Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Acta Biomater. 2021 Dec 9;140:338–349. doi: 10.1016/j.actbio.2021.12.008

Figure 5. In vitro antimicrobial activity of the hybrid nanocoatings against MRSA and P. aeruginosa.

Figure 5.

(a, b) CFU and (c. d) representative LIVE/DEAD stain CLSM images of (a, c) MRSA or (b, d) P. aeruginosa biofilms grown on the tested surfaces after 6 h incubation in quasi-static conditions. Asterisks indicate statistically significant differences between connected groups: * p-value<0.05; ** p-value<0.01; *** p-value<0.001; **** p-value<0.0001. Three biological replicates with three samples in each experiment for each group were performed for each bacteria strain (N=9). All scale bars are 100 μm.